Literature DB >> 28101192

C-peptide exhibits a late induction effect on matrix metallopeptidase-9 in high glucose-stimulated rat mesangial cells.

Junxia Wang1, Yanning Li1, Mingzhi Xu1, Dandan Li2, Yu Wang1, Jinsheng Qi2, Kunyu He2.   

Abstract

Insufficient matrix metalloproteinase (MMP)-9 and MMP-2 is considered to be a contributor of extracellular matrix (ECM) accumulation in diabetic nephropathy (DN). C-peptide can reverse fibrosis, thus exerting a beneficial effect on DN. Whether C-peptide induces MMP-9 and MMP-2 to reverse ECM accumulation is not clear. In the present study, in order to determine ECM metabolism, rat mesangial cells were treated with high glucose (HG) and C-peptide intervention, then the early and late effects of C-peptide on HG-affected MMP-9 and MMP-2 were evaluated. Firstly, it was confirmed that HG mainly suppressed MMP-9 expression levels. Furthermore, C-peptide treatment induced MMP-9 expression at 6 h and suppressed it at 24 h, revealing the early dual effects of C-peptide on MMP-9 expression. Subsequently, significant increase in MMP-9 expression at 72, 96 and 120 h C-peptide treatment was observed. These changes in MMP-9 protein content confirmed its expression changes following late C-peptide treatment. Furthermore, at 96 and 120 h C-peptide treatment reversed the HG-inhibited MMP-9 secretion, further indicating the late induction effect of C-peptide on MMP-9. The present results demonstrated that C-peptide exerted a late induction effect on MMP-9 in HG-stimulated rat mesangial cells, which may be associated with the underlying mechanism of C-peptide's reversal effects on DN.

Entities:  

Keywords:  C-peptide; diabetic nephropathy; extracellular matrix; matrix metalloproteinase-2; matrix metalloproteinase-9

Year:  2016        PMID: 28101192      PMCID: PMC5228027          DOI: 10.3892/etm.2016.3873

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  30 in total

1.  Differential expression and therapeutic efficacy of microRNA-346 in diabetic nephropathy mice.

Authors:  Yong Zhang; Hou-Qin Xiao; Yang Wang; Zhuo-Shun Yang; Long-Jun Dai; Yan-Cheng Xu
Journal:  Exp Ther Med       Date:  2015-04-30       Impact factor: 2.447

2.  Imbalance between MMP-2, 9 and TIMP-1 promote the invasion and metastasis of renal cell carcinoma via SKP2 signaling pathways.

Authors:  Hongsheng Lu; Xuequan Cao; Hui Zhang; Gang Sun; Guangmin Fan; Lili Chen; Siling Wang
Journal:  Tumour Biol       Date:  2014-07-02

3.  Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation.

Authors:  Szu-Yuan Li; Po-Hsun Huang; An-Hang Yang; Der-Cherng Tarng; Wu-Chang Yang; Chih-Ching Lin; Jaw-Wen Chen; Geert Schmid-Schönbein; Shing-Jong Lin
Journal:  Kidney Int       Date:  2014-03-26       Impact factor: 10.612

4.  Effects of C-peptide on glomerular and renal size and renal function in diabetic rats.

Authors:  B Samnegård; S H Jacobson; G Jaremko; B L Johansson; M Sjöquist
Journal:  Kidney Int       Date:  2001-10       Impact factor: 10.612

5.  Protein nitration promotes inducible nitric oxide synthase transcription mediated by NF-κB in high glucose-stimulated human lens epithelial cells.

Authors:  Yanning Li; Demei Liu; Yuan Liu; En Li; Hui Wang; Kun Liu; Jinsheng Qi
Journal:  Mol Cell Endocrinol       Date:  2013-02-27       Impact factor: 4.102

Review 6.  Diabetic nephropathy--emerging epigenetic mechanisms.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Nat Rev Nephrol       Date:  2014-07-08       Impact factor: 28.314

7.  Proinsulin C-peptide regulates ribosomal RNA expression.

Authors:  Emma Lindahl; Ulrika Nyman; Farasat Zaman; Carina Palmberg; Anna Cascante; Jawed Shafqat; Masaharu Takigawa; Lars Sävendahl; Hans Jörnvall; Bertrand Joseph
Journal:  J Biol Chem       Date:  2009-11-16       Impact factor: 5.157

Review 8.  The clinical potential of C-peptide replacement in type 1 diabetes.

Authors:  John Wahren; Asa Kallas; Anders A F Sima
Journal:  Diabetes       Date:  2012-04       Impact factor: 9.461

9.  Tribbles 3 regulates the fibrosis cytokine TGF- β 1 through ERK1/2-MAPK signaling pathway in diabetic nephropathy.

Authors:  Luwei Zhang; Jinhang Zhang; Xinnong Liu; Shengli Liu; Jun Tian
Journal:  J Immunol Res       Date:  2014-07-16       Impact factor: 4.818

10.  C-peptide prevents hyperglycemia-induced endothelial apoptosis through inhibition of reactive oxygen species-mediated transglutaminase 2 activation.

Authors:  Mahendra Prasad Bhatt; Young-Cheol Lim; JongYun Hwang; SungHun Na; Young-Myeong Kim; Kwon-Soo Ha
Journal:  Diabetes       Date:  2012-08-24       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.